U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Northern Fish Products, Inc. - 514554 - 02/28/2018
  1. Warning Letters

CLOSEOUT LETTER

Northern Fish Products, Inc. MARCS-CMS 514554 —

Recipient:
Northern Fish Products, Inc.

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

Seattle District Office
22215 261h Avenue SE, Suite 210
Bothell, Washington 98021 
 
 

February 28, 2018

CERTIFIED MAIL
RETURN RECEIPT REQUESTED

Ross R. Swanes, President
Northern Fish Products, Inc.
P.O. Box 9615
Tacoma, Washington 98409

Dear Mr. Swanes:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter SEA 17-12, dated April 25, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority.  The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Miriam R. Burbach
District Director
Program Division Director 

Back to Top